These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

445 related articles for article (PubMed ID: 33041830)

  • 1. Pathophysiology and Potential Therapeutic Candidates for COVID-19: A Poorly Understood Arena.
    Samaddar A; Grover M; Nag VL
    Front Pharmacol; 2020; 11():585888. PubMed ID: 33041830
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insights into antiviral mechanisms of remdesivir, lopinavir/ritonavir and chloroquine/hydroxychloroquine affecting the new SARS-CoV-2.
    Uzunova K; Filipova E; Pavlova V; Vekov T
    Biomed Pharmacother; 2020 Nov; 131():110668. PubMed ID: 32861965
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SARS-CoV-2: Recent Reports on Antiviral Therapies Based on Lopinavir/Ritonavir, Darunavir/Umifenovir, Hydroxychloroquine, Remdesivir, Favipiravir and other Drugs for the Treatment of the New Coronavirus.
    Costanzo M; De Giglio MAR; Roviello GN
    Curr Med Chem; 2020; 27(27):4536-4541. PubMed ID: 32297571
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Scoping Insight on Potential Prophylactics, Vaccines and Therapeutic Weaponry for the Ongoing Novel Coronavirus (COVID-19) Pandemic- A Comprehensive Review.
    Dash P; Mohapatra S; Ghosh S; Nayak B
    Front Pharmacol; 2020; 11():590154. PubMed ID: 33815095
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An Update on Antiviral Therapy Against SARS-CoV-2: How Far Have We Come?
    Indari O; Jakhmola S; Manivannan E; Jha HC
    Front Pharmacol; 2021; 12():632677. PubMed ID: 33762954
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostic approaches and potential therapeutic options for coronavirus disease 2019.
    Khan Z; Ghafoor D; Khan A; Ualiyeva D; Khan SA; Bilal H; Khan B; Khan A; Sajjad W
    New Microbes New Infect; 2020 Nov; 38():100770. PubMed ID: 33014380
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current therapeutic options for coronavirus disease 2019 (COVID-19)-lessons learned from severe acute respiratory syndrome (SARS) and Middle East Respiratory Syndrome (MERS) therapy: a systematic review protocol.
    Zhang ZL; Zhong H; Liu YX; Le KJ; Cui M; Yu YT; Gu ZC; Gao Y; Lin HW
    Ann Transl Med; 2020 Nov; 8(22):1527. PubMed ID: 33313272
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Repurposing Therapeutics for Potential Treatment of SARS-CoV-2: A Review.
    Santos J; Brierley S; Gandhi MJ; Cohen MA; Moschella PC; Declan ABL
    Viruses; 2020 Jun; 12(7):. PubMed ID: 32629804
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An overview of the safety, clinical application and antiviral research of the COVID-19 therapeutics.
    Wang D; Li Z; Liu Y
    J Infect Public Health; 2020 Oct; 13(10):1405-1414. PubMed ID: 32684351
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacological Strategies for COVID-19 - A Review of the Most Promising Repurposed Antiviral Drugs.
    Chopra D; Boparai JK; Bhandari B; Srivastava A; Gupta R
    Infect Disord Drug Targets; 2021; 21(7):e160921189260. PubMed ID: 33342420
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Review of Treatment of Coronavirus Disease 2019 (COVID-19): Therapeutic Repurposing and Unmet Clinical Needs.
    Chen PL; Lee NY; Cia CT; Ko WC; Hsueh PR
    Front Pharmacol; 2020; 11():584956. PubMed ID: 33364959
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment Options for Severe Acute Respiratory Syndrome, Middle East Respiratory Syndrome, and Coronavirus Disease 2019: a Review of Clinical Evidence.
    Hoang T; Anh TTT
    Infect Chemother; 2020 Sep; 52(3):317-334. PubMed ID: 32869558
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical Trials of Repurposed Antivirals for SARS-CoV-2.
    Martinez MA
    Antimicrob Agents Chemother; 2020 Aug; 64(9):. PubMed ID: 32631826
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Perspectives on monoclonal antibody therapy as potential therapeutic intervention for Coronavirus disease-19 (COVID-19).
    Shanmugaraj B; Siriwattananon K; Wangkanont K; Phoolcharoen W
    Asian Pac J Allergy Immunol; 2020 Mar; 38(1):10-18. PubMed ID: 32134278
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A global treatments for coronaviruses including COVID-19.
    Yousefi B; Valizadeh S; Ghaffari H; Vahedi A; Karbalaei M; Eslami M
    J Cell Physiol; 2020 Dec; 235(12):9133-9142. PubMed ID: 32394467
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potential Antiviral Drugs for SARS-Cov-2 Treatment: Preclinical Findings and Ongoing Clinical Research.
    Bimonte S; Crispo A; Amore A; Celentano E; Cuomo A; Cascella M
    In Vivo; 2020 Jun; 34(3 Suppl):1597-1602. PubMed ID: 32503817
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of ACE2 receptor and the landscape of treatment options from convalescent plasma therapy to the drug repurposing in COVID-19.
    Kumar P; Sah AK; Tripathi G; Kashyap A; Tripathi A; Rao R; Mishra PC; Mallick K; Husain A; Kashyap MK
    Mol Cell Biochem; 2021 Feb; 476(2):553-574. PubMed ID: 33029696
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Small-molecule Antiviral Agents in Ongoing Clinical Trials for COVID-19.
    Apaydın ÇB; Çınar G; Cihan-Üstündağ G
    Curr Drug Targets; 2021; 22(17):1986-2005. PubMed ID: 33588727
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An Update on Current Therapeutic Drugs Treating COVID-19.
    Wu R; Wang L; Kuo HD; Shannar A; Peter R; Chou PJ; Li S; Hudlikar R; Liu X; Liu Z; Poiani GJ; Amorosa L; Brunetti L; Kong AN
    Curr Pharmacol Rep; 2020; 6(3):56-70. PubMed ID: 32395418
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preclinical and Clinical Investigations of Potential Drugs and Vaccines for COVID-19 Therapy: A Comprehensive Review With Recent Update.
    Mia ME; Howlader M; Akter F; Hossain MM
    Clin Pathol; 2024; 17():2632010X241263054. PubMed ID: 39070952
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.